- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 15/20 - Carbocycles
Détention brevets de la classe C07H 15/20
Brevets de cette classe: 123
Historique des publications depuis 10 ans
|
8
|
10
|
4
|
8
|
13
|
2
|
6
|
6
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cipla USA, Inc. | 34 |
5 |
| Glycosynth Limited | 5 |
4 |
| The Coca-Cola Company | 2443 |
3 |
| Infectious Disease Research Institute | 44 |
3 |
| The University of British Columbia | 1546 |
3 |
| University of Georgia Research Foundation, Inc. | 1073 |
3 |
| Quralis Corporation | 24 |
3 |
| Centre National de La Recherche Scientifique | 11026 |
2 |
| Vertex Pharmaceuticals Incorporated | 1578 |
2 |
| CHDI Foundation, Inc. | 107 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1443 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2665 |
2 |
| The Governors of the University of Alberta | 878 |
2 |
| Ionis Pharmaceuticals, Inc. | 956 |
2 |
| PureCircle Sdn Bhd | 231 |
2 |
| TriAct Therapeutics, Inc. | 13 |
2 |
| The UAB Research Foundation | 668 |
2 |
| University of Washington through its Center for Commercialization | 505 |
2 |
| Washington University | 1743 |
2 |
| BioNTech SE | 801 |
2 |
| Autres propriétaires | 73 |